139 related articles for article (PubMed ID: 10476135)
1. Developing a protocol to prevent and treat pediatric central venous catheter occlusions.
Harris JL; Maguire D
J Intraven Nurs; 1999; 22(4):194-8. PubMed ID: 10476135
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.
Bagnall HA; Gomperts E; Atkinson JB
Pediatrics; 1989 Jun; 83(6):963-6. PubMed ID: 2657625
[TBL] [Abstract][Full Text] [Related]
3. Urokinase administration in pediatric patients with occluded central venous catheters.
Wachs T
J Intraven Nurs; 1990; 13(2):100-2. PubMed ID: 2313458
[TBL] [Abstract][Full Text] [Related]
4. Urokinase efficacy in the restoration of hemodialysis catheter function.
Meers C; Toffelmire EB
J CANNT; 1998; 8(2):17-9. PubMed ID: 9807329
[TBL] [Abstract][Full Text] [Related]
5. Predisposing factors, prevention, and management of central venous catheter occlusions.
Krzywda EA
J Intraven Nurs; 1999; 22(6 Suppl):S11-7. PubMed ID: 10865603
[TBL] [Abstract][Full Text] [Related]
6. Urokinase therapy in neonates with catheter related central venous thrombosis.
Wever ML; Liem KD; Geven WB; Tanke RB
Thromb Haemost; 1995 Feb; 73(2):180-5. PubMed ID: 7792727
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study.
Dillon PW; Jones GR; Bagnall-Reeb HA; Buckley JD; Wiener ES; Haase GM;
J Clin Oncol; 2004 Jul; 22(13):2718-23. PubMed ID: 15226339
[TBL] [Abstract][Full Text] [Related]
8. Clot lysis for thrombosed central venous catheters in pediatric patients.
Kellam B; Fraze D; Kanarek KS
J Perinatol; 1987; 7(3):242-4. PubMed ID: 3504465
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of obstruction and thrombosis due to central venous catheterization].
Leititis JU
Klin Padiatr; 1991; 203(6):420-3. PubMed ID: 1758144
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of central venous access device occlusion. Implications for nursing practice.
Bagnall-Reeb H
J Intraven Nurs; 1998; 21(5 Suppl):S115-21. PubMed ID: 9814286
[TBL] [Abstract][Full Text] [Related]
11. Management of central venous catheter occlusions and repairs.
Reed T; Phillips S
J Intraven Nurs; 1996; 19(6):289-94. PubMed ID: 9060354
[TBL] [Abstract][Full Text] [Related]
12. Central venous catheter occlusion.
Richardson D
Oncol Nurs Forum; 1999 May; 26(4):683. PubMed ID: 10337640
[No Abstract] [Full Text] [Related]
13. Recombinant tissue plasminogen activator for central venous access device occlusion.
Hooke C
J Pediatr Oncol Nurs; 2000 Jul; 17(3):174-8. PubMed ID: 10944865
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 6 years use of sodium hydroxide solution to clear partially occluded central venous catheters.
Bader SG; Balke P; Jonkers-Schuitema CF; Tas TA; Sauerwein HP
Clin Nutr; 2007 Feb; 26(1):141-4. PubMed ID: 17097197
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy extravasation: a consequence of fibrin sheath formation around venous access devices.
Mayo DJ; Pearson DC
Oncol Nurs Forum; 1995 May; 22(4):675-80. PubMed ID: 7675669
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a positive pressure device to prevent central venous catheter occlusion: results of a pilot study.
Rummel MA; Donnelly PJ; Fortenbaugh CC
Clin J Oncol Nurs; 2001; 5(6):261-5. PubMed ID: 11899627
[TBL] [Abstract][Full Text] [Related]
17. Restoration of flow following haemodialysis catheter thrombus. Analysis of rt-PA infusion in tunnelled dialysis catheters.
Davies J; Casey J; Li C; Crowe AV; McClelland P
J Clin Pharm Ther; 2004 Dec; 29(6):517-20. PubMed ID: 15584939
[TBL] [Abstract][Full Text] [Related]
18. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.
Svoboda P; Barton RP; Barbarash OL; Butylin AA; Jacobs BR; Lata J; Haire WD; Jaff MR; Firszt CM; Mouginis TL; Schuerr DM; Schulz GA; Schwartz LB; El-Shahawy MA
Crit Care Med; 2004 Oct; 32(10):1990-6. PubMed ID: 15483405
[TBL] [Abstract][Full Text] [Related]
19. Dilution of urokinase used to treat thrombus formation in central venous catheters.
Wiseman KC
ANNA J; 1997 Aug; 24(4):457-8. PubMed ID: 9325699
[No Abstract] [Full Text] [Related]
20. Review and update of the use of urokinase in the prevention and management of CVAD-related complications in pediatric oncology patients.
Simon A; Bode U; Lieber K; Beutel K; Fleischhack G
Am J Infect Control; 2008 Feb; 36(1):54-8. PubMed ID: 18241737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
